CNX THERAPEUTICS LIMITED

Active
Company number 03363032Private limited companyIncorporated 1997

Key figures

£43,228
Net assets 2024/25

† CNX THERAPEUTICS LIMITED filed these accounts on paper, so Companies House publishes them only as a scanned image. The figures for the years marked † were read automatically from the scan and kept only where the statements add up (for example net assets equal total equity), but a reading error is still possible — check the original accounts at Companies House.

Ratios

2024/25

Summary: CNX THERAPEUTICS LIMITED

What kind of company is it?

CNX THERAPEUTICS LIMITED is a private limited company registered with Companies House under company number 03363032. It was incorporated on 1 May 1997. Its status is active. The registered office is in London (EC1Y). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).

How is the company doing financially?

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files full accounts. Turnover was £26,757,353. Loss for the year was £3,137,099. Net assets were £43,228. Cash at bank and in hand was £6,903,521. Total assets were £132,864,385 and total liabilities £63,405,595. The company had an average of 21 employees.

Who runs and controls the company?

One person with significant control is registered. 1 of 2 registered charges are outstanding.

When are its next filings due?

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 15 May 2027.

Filed accounts2024/25
2024/25 †
Turnover26,757,353
Profit for the year-3,137,099
Cash at bank and in hand6,903,521
Total assets132,864,385
Total liabilities63,405,595
Net assets / total equity43,228
Average number of employees21

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

History

6 events
  1. Financial year 2024/25 endedAccounts: turnover £26.8m, net assets £43.2k, 21 employees
  2. Name changed to CNX THERAPEUTICS LIMITEDPreviously SUNOVION PHARMACEUTICALS EUROPE LTD.
  3. Solar Bidco Limited registered as a person with significant control
  4. Name changed to DAINIPPON SUMITOMO PHARMA EUROPE LTD.Previously SUNOVION PHARMACEUTICALS EUROPE LTD
  5. Name changed to SUNOVION PHARMACEUTICALS EUROPE LTD.Previously DAINIPPON SUMITOMO PHARMA EUROPE LTD.
  6. Company incorporatedPrivate limited company

Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.